FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

42692007: Naproxen sodium (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
71237019 Naproxen sodium en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
779619019 Naproxen sodium (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
827211000172111 naproxène sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naproxen sodium Is a Product containing naproxen (medicinal product) false Inferred relationship Some
Naproxen sodium Is a Naproxen (substance) false Inferred relationship Some
Naproxen sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Naproxen (substance) true Inferred relationship Some
Naproxen sodium Is a Propionic acid and/or propionic acid derivative (substance) false Inferred relationship Some
Naproxen sodium Is a Cyclooxygenase-1 inhibitor true Inferred relationship Some
Naproxen sodium Is a Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) true Inferred relationship Some
Naproxen sodium Is a Naphthalene true Inferred relationship Some
Naproxen sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cyclooxygenase-2 inhibitor true Inferred relationship Some
Naproxen sodium This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Cyclooxygenase-1 inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Naproxen sodium 275 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 375mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 550 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Product containing naproxen sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 220mg caplet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Product containing precisely naproxen sodium 220 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Product containing naproxen sodium and sumatriptan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 220mg/pseudoephedrine 120mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 275 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some 1
Naproxen sodium 275 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naproxen sodium Inferred relationship Some 1
Naproxen sodium 550 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some 1
Naproxen sodium 550 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 220 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 220 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naproxen sodium Inferred relationship Some 1
Naproxen sodium 220mg/pseudoephedrine 120mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 375mg gastro-resistant oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Naproxen sodium 500mg gastro-resistant oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naproxen sodium Inferred relationship Some
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each gastro-resistant oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Naproxen sodium Inferred relationship Some 1
Naproxen sodium 275 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 220 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Naproxen sodium 550 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Naproxen sodium Inferred relationship Some 1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen (as naproxen sodium) 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen (as naproxen sodium) 250 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen (as naproxen sodium) 375 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1
Product containing precisely naproxen (as naproxen sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naproxen sodium Inferred relationship Some 1

This concept is not in any reference sets

Back to Start